In the Boardroom
Refine Search
Pharmaceutical
Belgian pharma major UCB has appointed Steve Turley as managing director for the UK and Ireland. 16 November 2015
Pharmaceutical
The UK division of Japanese pharma company Takeda has appointed two new directors in a bid to drive forward its expertise in the specialty care sector. 13 November 2015
Pharmaceutical
After 24 years’ service to Boehringer Ingelheim, Professor Andreas Barner will retire as chairman of the board of managing directors on June 30, 2016, and will move to the Shareholders' Committee of Boehringer Ingelheim, a family-owned German pharma major. 6 November 2015
Pharmaceutical
German pharma company Merck has appointed Laszlo Radvanyi as head of global immuno-oncology research. 2 November 2015
Biotechnology
F-star, a biotech company originally founded in Vienna but now mainly based in the UK, has appointed Neil Brewis as chief scientific officer. 2 November 2015
Pharmaceutical
Swiss drug company Roche has appointed Richard Erwin as the new UK general manager. 23 October 2015
Pharmaceutical
Sorrento Therapeutics has appointed Jeffrey Su as executive vice president and chief operating officer. 19 October 2015
Pharmaceutical
Merck KGaA has appointed Stefan Oschmann as chief executive and chairman of the executive board. 13 October 2015
Biotechnology
Biopharma company XenoPort has replaced its chief executive at a moment when the company is refocusing its strategic efforts, causing shares to rise 12%. 5 October 2015
Pharmaceutical
The European Medicines Agency’s management board has nominated Guido Rasi as the executive director of the Agency. At an extraordinary session on October 1, the board selected Prof Rasi from a shortlist of candidates provided by the European Commission. 1 October 2015
Pharmaceutical
Danish insulin giant Novo Nordisk has appointed Stephen Gough as senior principal clinical scientist. 30 September 2015
Biotechnology
French biotech company Abivax has appointed Jean-Marc Steens as chief medical officer. 24 September 2015
Biotechnology
UK clinical-stage neurokinin receptor specialist company NeRRe Therapeutics has appointed Mary Kerr as chief executive. 23 September 2015
Biotechnology
German company leon-nanodrugs has appointed Theron Odlaug as chief executive and the chief executive of its newly-formed US subsidiary. 22 September 2015
Biotechnology
UK-based Bicycle Therapeutics has appointed Kevin Lee as chief executive officer. 21 September 2015
Pharmaceutical
Contract research and manufacturing organization Albany Molecular Research has made George Svokos chief operating officer, and Lori Henderson head of corporate business development. 14 September 2015
Biotechnology
EMD Serono, the biopharma division of German pharma company Merck, has appointed Scott Filosi as senior vice president of managed markets. 10 September 2015
Pharmaceutical
Netherlands-based Pharming Group has appointed Robin Wright as chief financial officer. 10 September 2015
Pharmaceutical
Immune Pharmaceuticals has named Boris Shor as executive director for research and development (R&D) and scientific partnerships. 9 September 2015
Biotechnology
Spanish biotech firm Laboratoris Sanifit says it has raised 36.6 million euros ($41 million) in a Series C financing round. 8 September 2015
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze